Back

Renal outcomes in patients with atrial fibrillation undergoing catheter ablation: a population-based study

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation catheter ablation outcome (2) Clinical EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Jung Hoon Sung

CHA University, Seongnam (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
Comparing GLP-1 agonists versus other weight loss interventions on atrial fibrillation recurrence after catheter ablation: a meta-regression analysis
Ms H. Li (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
Follow-up outcomes of atrial fibrillation ablation in patients with hypertrophic cardiomyopathy: a single-center analysis
Professor K. Aytemir (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Suboptimal ostial level isolation in pulmonary veins after cryoballoon ablation frequently indicates need for additional segmental ablations to improve outcomes
Doctor A. Strazdas (Brussels, BE)
Abstract Slides Video
Presentation thumbnail
Comparison of outcomes between males and females treated with left atrial appendage closure or oral anticoagulation after catheter ablation for atrial fibrillation: an OPTION subanalysis
Doctor O. wazni (Cleveland, US)
Abstract Slides
Presentation thumbnail
Development and validation of a new patient-centred quality of life measure for atrial fibrillation: the AF-PROM questionnaire
Doctor V. Kanthasamy (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation catheter ablation outcome (2)

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Outcomes of atrial fibrillation ablation in patients with chronic kidney disease
thumbnail
Congress Presentation
Early catheter ablation in atrial fibrillation patients recently hospitalized for worsening heart failure
thumbnail
Congress Presentation
Impact of renal impairment and other high bleeding risk factors on clinical outcomes among Asian patients with atrial fibrillation on edoxaban: a post hoc analysis of the ETNA-AF program

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources